A clear understanding of the role of PI (phosphoinositide) 3-kinases in supporting the haemostatic function of platelets has been slow to evolve. In fact, insight into the roles of individual PI 3-kinase isoforms in platelet function remains rudimentary. However, based on in vitro studies using wortmannin and LY294002, there is evidence for an important role for PI 3-kinases in regulating a broad range of functional platelet responses, including primary platelet adhesion, cytoskeletal remodelling and platelet aggregation. One of the critical platelet responses involves affinity regulation of the major platelet integrin αIIbβ3, the primary receptor mediating platelet aggregation and thrombus growth. The input signals regulating integrin αIIbβ3 can be divided into three main groups: (1) G q -coupled receptors linked to the activation of PLCβ (phospholipase Cβ); (2) G i -coupled receptors linked to the regulation of adenylate cyclase and Rap1b; and (3) adhesion receptor signalling involving Src kinase-dependent activation of PLCγ isoforms. PI 3-kinases have not been demonstrated to play a critical role in G q -dependent platelet activation; however, one or more PI 3-kinase isoforms appears to be important for G i -dependent activation of Rap1b and adhesion receptor activation of PLCγ isoforms. Thus distinct co-operative PI 3-kinase signalling mechanisms appear to play an important role in regulating the adhesive function of integrin αIIbβ3.
Introduction
PI (phosphoinositide) 3-kinases play key roles in regulating functional responses in a variety of haemopoietic cells, including neutrophils, monocytes, mast cells, eosinophils, and B-and T-cells [1] . There is considerable evidence from transgenic studies in mice for an important role for one or more PI 3-kinase isoforms in regulating leucocyte and lymphocyte functions necessary for normal inflammatory and immunological responses in vivo [2, 3] . The importance of PI 3-kinases in regulating the adhesive function of platelets, relevant to haemostasis and thrombosis, has been less clearly defined. Of the seven agonist-sensitive PI 3-kinases, at least four are known to be expressed at high levels in platelets, including members of class Ia (PI 3-kinase α and PI 3-kinase β), class Ib (PI 3-kinase γ ) and class II (PI 3-kinase C2α) [4] . PI 3-kinase δ has also recently been demonstrated in platelets, although its level of expression is much lower than in leucocytes [5] .
The haemostatic function of platelets is dependent on their ability to adhere rapidly to subendothelial matrix proteins (primary platelet adhesion) and to other activated platelets (platelet aggregation) at sites of vascular injury. This process is essential for the arrest of bleeding and subsequent vessel repair and, as such, these cells play a key role in maintaining the integrity of the vascular system (reviewed in [6] ).
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Pathologically, platelets have a central role in the development of a wide range of cardiovascular diseases due to their involvement in atherosclerotic and thrombotic processes. In fact, the excessive accumulation of platelets at sites of atherosclerotic plaque rupture represents the single most important pathogenic event precipitating acute myocardial infarction and thrombotic stroke, which combined represent the leading causes of death in industrialized societies. As a consequence, the platelet represents a major target for therapeutic intervention, with a great deal of effort focused on defining the signalling mechanisms regulating platelet adhesion and activation.
In this review we will discuss the involvement of PI 3-kinases in the regulation of the major platelet adhesion receptor, integrin αIIbβ3, with specific emphasis on the role that these kinases play in adhesion receptor and G i signalling. We will begin with a brief overview of the key adhesive molecules and agonist receptors regulating integrin αIIbβ3 activation and the important signalling pathways involved. The review will focus primarily on recent conceptual advances in the field, rather than providing a detailed discussion of specific PI 3-kinase signalling pathways. For more detailed information on platelet function, readers are referred to previous reviews [4, 6, 7] .
Integrin αIIbβ3 -the major platelet receptor mediating platelet aggregation and thrombus growth Primary platelet adhesion to the damaged vessel wall requires the synergistic contribution of multiple adhesionreceptor-ligand interactions. At least six adhesion receptors, including the leucine-rich glycoprotein receptor complex GPIb/V/IX, the integrins αIIbβ3, α2β1, α5β1 and α6β1 and the immunoglobulin receptor GPVI, are involved in primary adhesion ( Figure 1 ). The situation with platelet aggregation is less complex, with only two adhesion receptors involved in this process, namely GPIb/V/IX and integrin αIIbβ3. The former receptor plays a critical role in recruiting platelets to the site of injury, whereas the latter receptor mediates firm platelet adhesion and thrombus growth.
In general, the affinity/avidity regulation of integrin αIIbβ3 is the primary determinant regulating the rate and extent of platelet aggregation [8] . Integrins are subject to affinity regulation from signals emanating from within the cell, through a process of inside-out signalling (reviewed in [9] [10] [11] ). The initial signals promoting inside-out signalling can be triggered by a diverse array of adhesive substrates and soluble stimuli in vivo, that activate platelets through either tyrosinekinase-linked adhesion receptors or G-protein-coupled agonist receptors respectively ( Figure 1 ). Once activated, integrin αIIbβ3 engagement of adhesive ligands initiates the transduction of signals back into the cell via outside-in signalling processes [9] [10] [11] . There is now a considerable body of evidence supporting an important role for PI 3-kinase in regulating the bi-directional integrin αIIbβ3 signalling processes required for efficient platelet aggregation.
Input signals regulating integrin αIIbβ3 activation

Soluble platelet agonists
Efficient platelet activation requires the co-ordinated signalling function of multiple agonist receptors, the most important of which are the thrombin receptors [PAR1 (proteaseactivated receptor 1) and PAR4], the ADP purinergic receptors (P2Y 1 and P2Y 12 ) and the thromboxane receptors (TPα and TPβ) ( Figure 1 ). Each of these receptors induces platelet activation through G-protein-coupled receptors, with evidence from G q −/− mouse platelets demonstrating that activation of PLCβ (phospholipase Cβ) and PI turnover is the major signalling pathway used by these agonists to induce integrin αIIbβ3 activation [12] . There is currently limited evidence supporting an important role for PI 3-kinases in G q signalling in platelets; therefore this specific pathway will not be discussed in detail in this review. G i -coupled and adhesion receptor signalling appears to be partially dependent on the activation of one or more PI 3-kinase (PI3K) isoforms. The production of the PI 3-kinase lipid product PtdIns(3,4,5)P 3 (PIP 3 ), as well as the activation of Src kinases following ligation of GPIb/V/IX and GPVI-FcR γ -chain, suggest the involvement of class Ia PI 3-kinases, while the absence of PtdIns(3,4,5)P 3 generation following integrin αIIbβ3 activation raises the possibility that a class II PI 3-kinase isoform may be responsible for the generation of PtdIns(3,4)P 2 . The G i -coupled purinergic receptor P2Y 12 appears to play an important role in amplifying rather than initiating activation signals. It appears that class Ib PI 3-kinase is important in ADP-induced signalling; however, recent evidence also implicates the involvement of a class Ia PI 3-kinase isoform in this signalling pathway.
G i signalling
The other major class of G-proteins promoting integrin αIIbβ3 activation belong to the G i family. Platelets contain G i1 , G i2 , G i3 and G z , each coupling to specific agonist receptors [13] . The two most abundant G i family members, G i2 and G z , are coupled to the ADP purinergic receptor P2Y 12 and the α 2A -adrenoreceptor respectively. The importance of G i signalling for the potentiation of platelet activation is well established [14] , with evidence that G i -mediated signals synergise with most, if not all, primary platelet agonists, including thrombin [15] , thromboxane A 2 [16] and the ADP receptor P2Y 1 [17] , as well as activation initiated through GPVI [18] and the Fcγ RIIA receptor [19] . For many years, the consensus view was that G i enhanced platelet activation through the inhibition of adenylate cyclase, leading to a decrease in cellular cAMP levels. However, this has recently been challenged by the findings that pharmacological inhibitors of adenylate cyclase do not prevent the G idependent potentiation of platelet activation [20] . In fact, recent studies suggest a more important role for PI 3-kinases in this process [17, 21] .
In general, G i signalling on its own leads to weak PI 3-kinase activation and minimal platelet activation. In contrast, G i signals appear to play a major role in potentiating platelet PI 3-kinase responses induced by other platelet agonists. For example, accumulation of PtdIns(3,4)P 2 in thrombin-stimulated platelets is dependent on a parallel P2Y 12 -initiated pathway, with ADP scavengers inhibiting the production of this lipid product by nearly 80% [22] . Similarly, integrin αIIbβ3-mediated platelet adhesion to fibrinogen induces increases in PtdIns(3,4)P 2 levels which are dependent on secreted ADP [23] .
G i signalling downstream of P2Y 12 and α 2A -adrenergic receptor activation in platelets has also been demonstrated to activate the GTPase Rap1b [21] . Such activation is PI 3-kinase dependent, with some evidence for a role for PtdIns(3,4,5)P 3 [21] . Rap1b activation has been proposed to activate and stabilize integrin αIIbβ3, thereby potentiating platelet aggregation. The involvement of G βγ -activated PI 3-kinase γ in this event is controversial, with recent evidence implicating a class Ia PI 3-kinase [21, 24] .
Adhesion receptors
Efficient platelet adhesion requires the co-ordinated signalling function of multiple surface receptors. Each of the different classes of platelet adhesion receptors (leucine-rich glycoprotein, integrin and immunoglobulin) have distinct roles in the platelet adhesion/activation process. There is growing evidence that most, if not all, platelet adhesion receptors transduce signals via one or more Src kinase family members linked to the activation of PLCγ isoforms [25] [26] [27] . PI 3-kinases appear to play important roles in these signalling pathways, with evidence that these enzymes play a major role in promoting platelet activation downstream of GPIb/V/IX, GPVI and integrin αIIbβ3 [28, 29] (Figure 2 ).
GPIb/V/IX
The mechanism by which this receptor signals remains unknown, as it has no intrinsic tyrosine kinase activity, does not bind G-proteins, and is not phosphorylated on tyrosine residues. Nonetheless, the GPIb/V/IX complex was the first adhesion receptor demonstrated to activate the class Ia isoforms of PI 3-kinase [30] , and pharmacological PI 3-kinase inhibitors abolish vWf (von Willebrand factor)-induced integrin αIIbβ3 activation [29] . Furthermore, shear-induced binding of vWf to GPIb/V/IX induces PtdIns(3,4,5)P 3 production [28] , although, in this latter situation, most of the lipid formation is dependent on G i -dependent signalling. A key outstanding issue in the field is the contribution of PI 3-kinase to the initial activation of platelets through GPIb/V/IX, relative to its role in sustaining platelet activation through integrin αIIbβ3 and G i signalling.
GPVI
The GPVI-FcR γ -chain complex has been identified to play a central role in mediating platelet adhesion and subsequent activation by both fibrillar and soluble forms of collagen [31, 32] . The FcR γ -chain, a transmembrane protein that possesses ITAMs (immunoreceptor tyrosine-based activating motifs) within its cytoplasmic tail, is the critical signalling element of the GPVI-FcR γ -chain complex [33] . Crosslinking of the GPVI-FcR γ -chain complex triggers a host of signalling events that ultimately lead to the activation of Syk and PLCγ 2 [33] . The activation of PI 3-kinase is an important feature of collagen-induced platelet activation. Selective ligation of GPVI using CRP (collagen-related peptide) induces the formation of PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 [34] . The formation of these lipid products is mediated almost exclusively by class Ia PI 3-kinases, as the functional response of platelets from p85α-deficient mice to collagen and CRP were significantly impaired [35] . The exact mechanism by which PI 3-kinase regulates GPVI-FcR γ -chain signalling has yet to be defined; however, studies have demonstrated the association of PI 3-kinase with a number of signalling elements involved in collagen activation. For example, collagen stimulation of platelets induces the association of class Ia PI 3-kinases with the tyrosinephosphorylated forms of the FcR γ -chain and the adapter protein LAT (linker for activator of T-cells) [36] . In addition, PtdIns(3,4,5)P 3 can interact directly with PLCγ 2 [37] .
Integrin αIIbβ3
The precise mechanism by which integrins transduce signals has not been fully elucidated, although one proposed mechanism involves signalling processes similar to that utilized by ITAM-bearing receptors [e.g. GPVI-(FcRγ -chain)], at least in the context of PLCγ activation and calcium flux [25, 38] . There is abundant evidence that PI 3-kinases play a major role in integrin αIIbβ3 outside-in signalling relevant to several key platelet functional responses, including primary platelet adhesion, spreading and platelet aggregation. For example, early studies examining the generation of PI 3-kinase lipid products demonstrated a major role for integrin αIIbβ3 in promoting agonist-induced PtdIns(3,4)P 2 generation, necessary for sustaining platelet aggregation [39] . More direct evidence that PtdIns(3,4)P 2 is generated downstream of integrin αIIbβ3 was derived from studies of platelet adhesion on fibrinogen. Platelet spreading on this matrix led to the cellular accumulation of PtdIns(3,4)P 2 [23] , a signalling event that is critical for subsequent calcium mobilization and lamellipodial extension. The PI 3-kinase isoforms involved in integrin αIIbβ3 signalling remain unclear, although the conspicuous absence of PtdIns(3,4,5)P 3 generation following integrin αIIbβ3 ligation has raised the possibility that a class II PI 3-kinase isoform, possibly PI 3-kinase C2α, may be the major isoform responsible for PtdIns(3,4)P 2 generation [40, 41] .
There is a growing body of evidence demonstrating a potentially important role for PI 3-kinases in transducing signals downstream of each of the major platelet adhesion receptors linked to PLCγ 2 activation and cytosolic calcium flux [25] [26] [27] 34, 38] . It remains to be established whether all platelet integrins utilize such signalling processes and which PI 3-kinase isoforms are involved.
Role of PI 3-kinases in supporting the haemostatic function of platelets
Progress in defining roles for the individual PI 3-kinase isoforms in platelet function has been hampered by the lack of available mouse models and of isoform-selective pharmacological inhibitors. To date, no specific bleeding problems have been described in mice lacking the δ or γ isoforms, suggesting that neither of these family members have an essential role in the haemostatic process. Even p85α-deficient mice, which contain less than 5% of all class Ia isoforms in platelets [35] , do not suffer from a significant bleeding problem. This suggests that a low level of PI 3-kinase activity is sufficient for platelet haemostatic function or, alternatively, that class Ia PI 3-kinases do not play a critical role in this process. Fatal thromboembolism in response to ADP stimulation has been reported to be significantly reduced in mice deficient in PI 3-kinase γ [42] , providing confirmation in vivo that this isoform plays a potentially important role in pathological platelet functional responses.
Outstanding issues
While a clearer understanding of the roles of PI 3-kinases in adhesion receptor and G i signalling is emerging, there is still much to be learnt with respect to the mechanisms by which PI 3-kinases regulate integrin αIIbβ3. For example, while Consideration of the input signals leading to integrin αIIbβ3 activation is complex, as a number of adhesive substrates and soluble stimuli contribute to this process. For example, thrombin initiates platelet activation through its G-protein-coupled receptors, PAR1 and PAR4. Integrin activation induced by this pathway is mediated mainly through Gα subunit-mediated PLCβ activation and PI turnover, although there is some evidence that the G-protein subunits can also trigger the activation of PI 3-kinase (PI3K) and Akt. In addition, thrombin stimulation triggers the release of exogenous agonists such as ADP, which may enhance integrin αIIbβ3 activation through a PI 3-kinase/Rap1b-dependent pathway. Finally, the subsequent engagement of adhesive ligands by active integrin αIIbβ3 stimulates the activation of PI 3-kinase and PLCβ through outside-in signalling processes that feed back to sustain integrin αIIbβ3 activation.
it is well known that thrombin and other soluble agonists utilize PI 3-kinase signalling pathways to induce integrin αIIbβ3 activation [4, 7] , it is presently unclear whether this is primarily as a result of their direct involvement in PAR1/4 receptor inside-out signalling, or secondary to their contribution to integrin αIIbβ3 outside-in and/or G i signalling (Figure 3 ). In addition, there is currently limited information on the role of Akt/protein kinase B in regulating integrin αIIbβ3 activation, a potentially important issue given that serine/threonine phosphorylation events have a clear role in promoting activation of integrin αIIbβ3. Furthermore, a clear understanding of the importance of individual PI 3-kinase isoforms in regulating integrin αIIbβ3 activation remains elusive, although considerable progress in this area can be anticipated in the near future with the recent development of isoform-selective PI 3-kinase inhibitors and the growing number of mouse models available to examine PI 3-kinase signalling processes.
A major outstanding issue relates to the importance of PI 3-kinase signalling processes in promoting platelet thrombus growth. Evidence supporting an important role in this process stems from findings in perfusion-based adhesion assays in which inhibition of PI 3-kinases inhibits platelet adhesion and aggregation on a vWf substrate [29, 43, 44] . Similarly, PI 3-kinases play a major role in shear-activation of platelets, a process dependent on the sequential binding of vWf to GPIb and integrin αIIbβ3 [28, 29] . The importance of PI 3-kinases in promoting platelet adhesion and aggregation on other thrombogenic substrates, including collagen, fibronectin and laminin, has been less clearly defined, but will be important given the role that these ligands play in promoting platelet thrombus formation. Other aspects of platelet function in which PI 3-kinases are likely to play a major role include the sustained activation of integrin αIIbβ3. Typically, many of the G q -dependent platelet-activating signals are short-lived, due to receptor down-regulation. Sustained platelet activation therefore requires the synergistic contribution of other input signals, particularly G i and adhesion receptor signalling. Thus it is likely that PI 3-kinases are involved in both promoting and maintaining integrin αIIbβ3 activation, necessary for stable thrombus growth.
